Premium
The Fluorescent Probe Prodan Characterizes the Warfarin Binding Site on Human Serum Albumin
Author(s) -
Moreno F.,
Cortijo M.,
GonzálezJiménez J.
Publication year - 1999
Publication title -
photochemistry and photobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 131
eISSN - 1751-1097
pISSN - 0031-8655
DOI - 10.1111/j.1751-1097.1999.tb05299.x
Subject(s) - fluorescence , human serum albumin , chemistry , warfarin , serum albumin , biophysics , human albumin , albumin , binding site , biochemistry , biology , medicine , optics , atrial fibrillation , physics
— The fluorescent probe Prodan (6‐propionyl‐2‐dimethyl‐aminonaphthalene) binds with high affinity to human serum albumin (HSA). The spectral characteristics of the Prodan bound to the protein are very different from the free Prodan in solution. These differences allowed the spectra to be deconvoluted into log‐normal bands in order to quantify the bound and unbound ligand and to calculate the binding constant at different temperatures. From such temperature dependence, we found the binding to be exothermic with a van't Hoff enthalpy of ‐22.8 kJ mol ‐1 . Thermodynamic analysis suggests that the in teraction may be mainly caused by hydrophobic forces and electrostatic interactions. The above analysis of the spectra and the measures of the fluorescence polarization during the successive presence of six specific drugs suggest that the Prodan binding site corresponds with the warfarin binding site on HSA, whereas under the present experimental conditions the other characteristic binding sites of HSA were not affected. Thus, this fluorescent probe provides a rapid and simple means for the characterization of a specific binding site on HSA and also for detecting potential or nonspecific drug‐protein interactions.